Ophthalmology · Flushing, NY
NPI
1457383150
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
16110 Union Tpke
Flushing, NY, 11366
Phone (718) 380-5070
Groups this clinician bills Medicare through
Medicare paid, 2024
$156K
1,888 services
Medicare patients, 2024
410
Average age 76
Drug cost, 2024
$3.1M
6,210 prescriptions
Company payments, 2025
$73K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard Najac was code 92014 (ophthalmological e&m), 527 times for 351 patients. In total Richard Najac billed 1,888 services in 27 codes, and Medicare paid $156K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 527 | 351 | $96.47 | $51K |
| 92250 Angiography | Office | 352 | 315 | $28.96 | $10K |
| 92012 Ophthalmological E&M | Office | 337 | 194 | $71.59 | $24K |
| 92020 Ophthalmological E&M | Office | 143 | 143 | $22.99 | $3,288 |
| 92083 Vision, Hearing, and Speech Services | Office | 128 | 127 | $53.17 | $6,805 |
| 92133 Computerized Ophthalmic Imaging | Office | 93 | 89 | $27.62 | $2,568 |
| 92136 Ultrasound - Nonspecific | Office | 81 | 42 | $32.59 | $2,640 |
| 66984 Cataract Surgery | Facility | 62 | 37 | $445.97 | $28K |
| 92004 Ophthalmological E&M | Office | 54 | 54 | $125.12 | $6,756 |
| 92134 Computerized Ophthalmic Imaging | Office | 32 | 29 | $34.69 | $1,110 |
| 68761 Eye | Office | 19 | 18 | $170.42 | $3,238 |
| 67820 Eye | Office | 19 | 11 | $17.08 | $325 |
By year: 2022 $160K for 1,858 services; 2023 $162K for 1,978 services; 2024 $156K for 1,888 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard Najac prescribed most often to Medicare patients was Latanoprost, with 925 prescriptions and refills. In total Richard Najac wrote 6,210 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 925 | 1,507 | 184 | $7,720 |
| Restasis Cyclosporine | 857 | 1,246 | 245 | $743K |
| Prednisolone Acetate Generic | 575 | 824 | 162 | $32K |
| Miebo Perfluorohexyloctane/Pf | 398 | 420 | 136 | $305K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 369 | 630 | 78 | $5,246 |
| Xiidra Lifitegrast | 267 | 358 | 73 | $236K |
| Ketorolac Tromethamine Generic | 264 | 340 | 90 | $6,186 |
| Azelastine Hcl Generic | 227 | 309 | 77 | $3,964 |
| Ofloxacin Generic | 226 | 259 | 94 | $3,400 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 169 | 171 | 78 | $6,761 |
| Brimonidine Tartrate Generic | 159 | 293 | 36 | $17K |
| Lumigan Bimatoprost | 152 | 259 | 38 | $69K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 138 | 143 | 61 | $1,134 |
| Combigan Brimonidine Tartrate/Timolol | 123 | 200 | 22 | $40K |
| Rhopressa Netarsudil Mesylate | 116 | 158 | 26 | $48K |
Brand drugs: 3,561 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard Najac $73K ($73K in general payments such as food, travel and fees) from 16 companies. The largest payer was Bausch & Lomb Americas Inc. with $46K.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 78 | $46K |
| Dompe US, Inc. | 32 | $22K |
| Abbvie Inc. ABBV | 9 | $1,355 |
| Alcon Vision LLC ALC | 26 | $1,230 |
| Tarsus Pharmaceuticals, Inc. TARS | 7 | $525 |
| LENSAR, Inc. LNSR | 1 | $358 |
| Biotissue Holdings Inc. | 5 | $328 |
| Harrow Eye, LLC | 7 | $325 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 9 | $294 |
| Sight Sciences, Inc. SGHT | 2 | $207 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.